Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
RLYB compared with VYNE: revenue, margins and what each company keeps, and the suppliers and customers both name
RLYB
Rallybio Corp
Change
Mkt cap
Revenue
Revenue
VYNE
VYNE Therapeutics Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
RLYB
Rallybio Corp
vs
VYNE
VYNE Therapeutics Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
RLYB
No earnings history for RLYB.
VYNE
Report
implied
realized
× implied
Aug 14 '26
—
▼
−0.54%
—
Jul 29 '26
—
▲
+8.56%
—
Nov 6 '25
—
▲
+4.59%
—
Aug 14 '25
—
▲
+0.69%
—
= implied
RLYB realized, solid
VYNE realized, hatched
One scale, both sides: full bar = 9%
× = |realized| ÷ implied
Source: market data
RLYB
Rallybio Corp
Change
15.89
▲
+0.79%
Mkt cap
$84.9M
Revenue
$212,000
Q1 FY26
Revenue
$858,000
FY25
VYNE
VYNE Therapeutics Inc.
Change
18.00
▲
+0.39%
Regular session
Nov 3 '26
Mkt cap
—
Revenue
—
Revenue
—
vs
Compare
Regular session
Nov 3 '26
RLYB
Rallybio Corp
vs
VYNE
VYNE Therapeutics Inc.
15.89
▲
+0.79%
Price
18.00
▲
+0.39%
$84.9M
Mkt cap
—
Q1 FY26
$212,000
Revenue
—
FY25
$858,000
Revenue
—
Change
Change
RLYB
15.89
▲
+0.79%
vs
VYNE
18.00
▲
+0.39%
Regular session
Nov 3 '26